# OLUMIANT
> **ANDA217585** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2025-08-08
## Drug
- **FDA Application Number:** ANDA217585
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLUMIANT
- **Generic name:** Baricitinib
- **Active ingredients:** BARICITINIB
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **First approval:** 2025-08-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217585)
---
*MORVS · CC0 1.0*